Syringocystadenocarcinoma papilliferum in situ originating from the perianal skin

APMIS

Volumn 117, Issue 2, 2009, Pages 148-150

  Langner, Cord ^a   Ott, Arthur ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN 19; CYTOKERATIN 5; CYTOKERATIN 6; CYTOKERATIN 7; KI 67 ANTIGEN;

AGED; ANAMNESIS; CANCER DIAGNOSIS; CARCINOMA IN SITU; CASE REPORT; CLINICAL FEATURE; EPITHELIUM; HIDRADENOMA; HISTOPATHOLOGY; HUMAN; LETTER; MALE; PLASMA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SYRINGOCYSTADENOCARCINOMA PAPILLIFERUM IN SITU;

AGED; AGED, 80 AND OVER; ANUS NEOPLASMS; CARCINOMA IN SITU; CYSTADENOCARCINOMA, PAPILLARY; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; SWEAT GLAND NEOPLASMS; SYRINGOMA;

EID: 60349107326     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2008.00027.x     Document Type: Letter

References (6)

1. Arai Y, Kusakabe H, Kiyokane K. A case of syringocystadenocarcinoma papilliferum in situ occurring partially in syringocystadenoma papilliferum. J Dermatol 2003 30 : 146 50.
2. Woestenborghs H, Van Eyken P, Dans A. Syringocystadenocarcinoma papilliferum in situ with pagetoid spread: a case report. Histopathology 2006 48 : 869 70.
3. Park SH, Shin YM, Shin DH, Choi JS, Kim KH. Syringocystadenocarcinoma papilliferum: a case report. J Korean Med Sci 2007 22 : 762 5.
4. Hobbs CM, Lowry MA, Owen D, Sobin LH. Anal gland carcinoma. Cancer 2001 92 : 2045 9.
5. Lisovsky M, Patel K, Cymes K, Chase D, Bhuiya T, Morgenstern N. Immunophenotypic characterization of anal gland carcinoma: loss of p63 and cytokeratin 5/6. Arch Pathol Lab Med 2007 131 : 1304 11.
6. Plumb SJ, Argenyi ZB, Stone MS, De Young BR. Cytokeratin 5/6 immunostaining in cutaneous adnexal neoplasms and metastatic adenocarcinoma. Am J Dermatopathol 2004 26 : 447 51.